SAN DIEGO, May 8, 2023 /PRNewswire/ -- Illumina (NASDAQ: ILMN ), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter highlighting the strength of its Board and noting that Carl Icahn's "plan" for Illumina is sloppy and uninformed.